Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yixun Wu"'
Publikováno v:
Future Oncology. 17:1865-1877
Retrospective observational research relies on databases that do not routinely record lines of therapy or reasons for treatment change. Standardized approaches to estimate lines of therapy were developed and evaluated in this study. A number of rules
Publikováno v:
Journal of Clinical Oncology. 39:e15575-e15575
e15575 Background: Colorectal cancer (CRC) is the 3rd leading cause of cancer-related deaths in the US. Anti-epidermal growth factor receptor agents improve outcomes of patients with metastatic CRC (mCRC) and are used in multiple lines of therapy. Ho
Publikováno v:
Journal of Clinical Oncology. 39:e15568-e15568
e15568 Background: Anti-epidermal growth factor receptor agents are increasingly used in later lines of therapy for the treatment of metastatic colorectal cancer (mCRC). However, the real-world time on treatment (TOT) and overall survival (OS) of pat
Publikováno v:
Journal of Medical Economics. 20:850-862
The objective of this study was to quantify the current and to project future patient and insurer costs for the care of patients with non-small cell lung cancer in the US.An analysis of administrative claims data among patients diagnosed with non-sma
Autor:
Zhanglin Lin Cui, William R. Schelman, Astra M. Liepa, Xiaohong Li, Yixun Wu, Sarah M Abraham, Lisa M. Hess
Publikováno v:
Journal of gastrointestinal cancer. 49(1)
This study investigated the patient perspective during cancer treatment and throughout the survivorship period and to understand how the patient experience may be related to choices for the treatment of gastric cancer. Eligible patients in the Vector
Publikováno v:
Journal of Thoracic Oncology. 11:S315-S316
Publikováno v:
Annals of the New York Academy of Sciences. 904:210-213